OpGen Inc (OPGN)

[mick]

TEST TEST TEST, LATEST NEWS, 4.14.20, https://curetis.com/
OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update MORE
4.01.20
OpGen and Curetis Successfully Close their Business Combination Transaction MORE

https://www.opgen.com/

businesses to build stronger diagnostic solutions for severe infections.
LEARN MORE
Curetis
Menu
Products
About Us
News
Blog
Resources
Careers
Contact
Fast & Simple Syndromic Testing for Severe Infections – Improving Patient Outcomes


Antibiotic resistant microorganisms are a global health threat*
Priority number one is to help detect pathogens rapidly, including associated antibiotic resistance genes
OUR SOLUTION

The Unyvero A50 Solution
With the Unyvero A50 Solution, Curetis has developed a molecular diagnostics system for reliable and extremely rapid diagnosis of severe infectious diseases within just 4-5 hours. The system uses powerful multiplex PCR technology and syndromic testing to detect a wide variety of microorganisms, antibiotic resistance markers, or toxins.


RAPID
Results in 4-5 hours versus 1-4 days

SIMPLE
Sample-to-answer, easy workflow

RELIABLE
High sensitivity and specificity for clinically actionable answers

COMPREHENSIVE
Broad syndromic panels for major infectious diseases

LEARN ABOUT UNYVERO A50 SOLUTION

Unyvero A50 Applications for Major Infectious Disease

HPN — Hospitalized Pneumonia
HPN Solution


BCU — Blood Culture
Analyzes the DNA of 103 pathogens and resistance genes from a positive blood cultures for fast diagnostics of blood stream infections.
BCU Solution


IAI — Intra-Abdominal Infection
IAI Solution


UTI — Urinary Tract Infection
UTI Solution


ITI — Implant & Tissue Infection
ITI Solution